GT Biopharma, Inc. (GTBP)
NASDAQ · Healthcare
GT Biopharma, Inc. Revenue 2010–2020
GT Biopharma, Inc. annual/quarterly revenue history and growth rate from 2010 to 2021. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- GT Biopharma, Inc. revenue for the quarter ending September 30, 2021 was 0.
- GT Biopharma, Inc. revenue for the twelve months ending September 30, 2021 was 0.
- GT Biopharma, Inc. annual revenue for 2020 was 0.
- GT Biopharma, Inc. annual revenue for 2019 was 0.
- GT Biopharma, Inc. annual revenue for 2017 was 0.
- GT Biopharma, Inc. annual revenue for 2016 was 0.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GT Biopharma, Inc. Market Cap — FAQ
GT Biopharma, Inc. (GTBP) market cap over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GTBP's market cap history?
The chart and table above show GT Biopharma, Inc.'s market cap by year and by quarter, including the growth rate.